6tti - Revision history

OCA at 10:19, 22 May 2024

2024-05-22T10:19:10Z

← Older revision		Revision as of 10:19, 22 May 2024
Line 3:		Line 3:
	<SX load='6tti' size='340' side='right' viewer='molstar' caption='[[6tti]], [[Resolution\|resolution]] 2.50Å' scene=''>		<SX load='6tti' size='340' side='right' viewer='molstar' caption='[[6tti]], [[Resolution\|resolution]] 2.50Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[6tti]] is a 4 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6TTI OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=6TTI FirstGlance]. <br>		<table><tr><td colspan='2'>[[6tti]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6TTI OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6TTI FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=FBP:BETA-FRUCTOSE-1,6-DIPHOSPHATE'>FBP</scene>, <scene name='pdbligand=NXE:~{N}-[3-(trifluoromethyl)-1,2-oxazol-5-yl]ethanamide'>NXE</scene~~></td></tr>~~		</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution\|Resolution]] 2.5Å</td></tr>
	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">PKM, OIP3, PK2, PK3, PKM2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>		<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=FBP:BETA-FRUCTOSE-1,6-DIPHOSPHATE'>FBP</scene>, <scene name='pdbligand=NXE:~{N}-[3-(trifluoromethyl)-1,2-oxazol-5-yl]ethanamide'>NXE</scene></td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Pyruvate_kinase Pyruvate kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.40 2.7.1.40] </span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6tti FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6tti OCA], [https://pdbe.org/6tti PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6tti RCSB], [https://www.ebi.ac.uk/pdbsum/6tti PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6tti ProSAT]</span></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=6tti FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6tti OCA], [~~http~~://pdbe.org/6tti PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6tti RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6tti PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6tti ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
	[~~[http~~://www.uniprot.org/uniprot/KPYM_HUMAN KPYM_HUMAN]] Glycolytic enzyme that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate (PEP) to ADP, generating ATP. Stimulates POU5F1-mediated transcriptional activation. Plays a general role in caspase independent cell death of tumor cells. The ratio betwween the highly active tetrameric form and nearly inactive dimeric form determines whether glucose carbons are channeled to biosynthetic processes or used for glycolytic ATP production. The transition between the 2 forms contributes to the control of glycolysis and is important for tumor cell proliferation and survival.<ref>PMID:17308100</ref> <ref>PMID:18191611</ref> <ref>PMID:21620138</ref>		[https://www.uniprot.org/uniprot/KPYM_HUMAN KPYM_HUMAN] Glycolytic enzyme that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate (PEP) to ADP, generating ATP. Stimulates POU5F1-mediated transcriptional activation. Plays a general role in caspase independent cell death of tumor cells. The ratio betwween the highly active tetrameric form and nearly inactive dimeric form determines whether glucose carbons are channeled to biosynthetic processes or used for glycolytic ATP production. The transition between the 2 forms contributes to the control of glycolysis and is important for tumor cell proliferation and survival.<ref>PMID:17308100</ref> <ref>PMID:18191611</ref> <ref>PMID:21620138</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 20:		Line 19:
	</div>		</div>
	<div class="pdbe-citations 6tti" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 6tti" style="background-color:#fffaf0;"></div>

			==See Also==
			*[[Pyruvate kinase 3D structures\|Pyruvate kinase 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</SX>		</SX>
	[[Category: ~~Human~~]]		[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	~~[[Category: Pyruvate kinase]]~~		[[Category: Bunkoczi G]]
	[[Category: Bunkoczi, G]]		[[Category: Dong J]]
	[[Category: Dong, J]]		[[Category: Hartshorn MJ]]
	[[Category: Hartshorn~~, M J~~]]		[[Category: Jhoti H]]
	[[Category: Jhoti, H]]		[[Category: Reeks J]]
	[[Category: Reeks, J]]		[[Category: Saur M]]
	[[Category: Saur, M]]		[[Category: Williams PA]]
	[[Category: Williams~~, P A]]~~
	~~[[Category: Cytosolic protein]]~~
	~~[[Category: Fbdd]]~~
	~~[[Category: Pkm2~~]]

OCA at 06:33, 11 April 2020

2020-04-11T06:33:48Z

← Older revision		Revision as of 06:33, 11 April 2020
Line 3:		Line 3:
	<SX load='6tti' size='340' side='right' viewer='molstar' caption='[[6tti]], [[Resolution\|resolution]] 2.50Å' scene=''>		<SX load='6tti' size='340' side='right' viewer='molstar' caption='[[6tti]], [[Resolution\|resolution]] 2.50Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[6tti]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6TTI OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=6TTI FirstGlance]. <br>		<table><tr><td colspan='2'>[[6tti]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6TTI OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6TTI FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=FBP:BETA-FRUCTOSE-1,6-DIPHOSPHATE'>FBP</scene>, <scene name='pdbligand=NXE:~{N}-[3-(trifluoromethyl)-1,2-oxazol-5-yl]ethanamide'>NXE</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=FBP:BETA-FRUCTOSE-1,6-DIPHOSPHATE'>FBP</scene>, <scene name='pdbligand=NXE:~{N}-[3-(trifluoromethyl)-1,2-oxazol-5-yl]ethanamide'>NXE</scene></td></tr>
	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">PKM, OIP3, PK2, PK3, PKM2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>		<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">PKM, OIP3, PK2, PK3, PKM2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Pyruvate_kinase Pyruvate kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.40 2.7.1.40] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Pyruvate_kinase Pyruvate kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.40 2.7.1.40] </span></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=6tti FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6tti OCA], [http://pdbe.org/6tti PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6tti RCSB], [http://www.ebi.ac.uk/pdbsum/6tti PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6tti ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6tti FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6tti OCA], [http://pdbe.org/6tti PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6tti RCSB], [http://www.ebi.ac.uk/pdbsum/6tti PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6tti ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==

OCA at 01:02, 7 March 2020

2020-03-07T01:02:49Z

@@ Line 1: / Line 1: @@
-The entry 6tti is ON HOLD
+==PKM2 in complex with Compound 6==
-Authors:
+Fragment-based drug discovery using cryo-EM.,Saur M, Hartshorn MJ, Dong J, Reeks J, Bunkoczi G, Jhoti H, Williams PA Drug Discov Today. 2019 Dec 23. pii: S1359-6446(19)30465-9. doi:, 10.1016/j.drudis.2019.12.006. PMID:31877353<ref>PMID:31877353</ref>
-Description:
+From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-[[Category: Unreleased Structures]]
+</div>

OCA: Protected "6tti" [edit=sysop:move=sysop]

2020-01-08T06:03:01Z

Protected "6tti" [edit=sysop:move=sysop]

← Older revision	Revision as of 06:03, 8 January 2020
(No difference)

OCA: New page: '''Unreleased structure''' The entry 6tti is ON HOLD Authors: Description: Category: Unreleased Structures

2020-01-08T06:02:59Z

New page: '''Unreleased structure''' The entry 6tti is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 6tti is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]